These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S. Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [Abstract] [Full Text] [Related]
4. Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function. Kitai T, Grodin JL, Kim YH, Tang WH. Circ Heart Fail; 2017 Feb; 10(2):e003603. PubMed ID: 28130379 [Abstract] [Full Text] [Related]
5. Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR. Ikeda Y, Inomata T, Kida K, Shibagaki Y, Sato N, Izumi T, Ako J, Kanagawa Aquaresis Investigators. Heart Vessels; 2019 Mar; 34(3):442-451. PubMed ID: 30259172 [Abstract] [Full Text] [Related]
7. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure. Ter Maaten JM, Valente MA, Damman K, Cleland JG, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Bloomfield DM, Cotter G, Davison B, Subacius H, van Veldhuisen DJ, van der Meer P, Hillege HL, Gheorghiade M, Voors AA. Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853 [Abstract] [Full Text] [Related]
11. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure. Testani JM, Hanberg JS, Cheng S, Rao V, Onyebeke C, Laur O, Kula A, Chen M, Wilson FP, Darlington A, Bellumkonda L, Jacoby D, Tang WH, Parikh CR. Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915 [Abstract] [Full Text] [Related]
12. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial. Balsam P, Ozierański K, Tymińska A, Główczyńska R, Peller M, Fojt A, Cacko A, Sieradzki B, Bakuła E, Markulis M, Kowalik R, Huczek Z, Filipiak KJ, Opolski G, Grabowski M. Trials; 2017 Jan 23; 18(1):36. PubMed ID: 28114980 [Abstract] [Full Text] [Related]
13. FGF-23 (Fibroblast Growth Factor-23) and Cardiorenal Interactions. Ivey-Miranda JB, Stewart B, Cox ZL, McCallum W, Maulion C, Gleason O, Meegan G, Amatruda JG, Moreno-Villagomez J, Mahoney D, Turner JM, Wilson FP, Estrella MM, Shlipak MG, Rao VS, Testani JM. Circ Heart Fail; 2021 Nov 23; 14(11):e008385. PubMed ID: 34689571 [Abstract] [Full Text] [Related]
14. Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis. Fukui M, Tsujino T, Hirotani S, Ito H, Yamamoto K, Akasaka T, Hirano Y, Ohte N, Daimon T, Nakatani S, Kawabata M, Masuyama T. Heart Vessels; 2017 Jul 23; 32(7):865-871. PubMed ID: 28105515 [Abstract] [Full Text] [Related]
19. Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study. Tominaga N, Kida K, Inomata T, Sato N, Izumi T, Akashi YJ, Shibagaki Y. Am J Nephrol; 2017 Jul 23; 46(5):417-426. PubMed ID: 29130954 [Abstract] [Full Text] [Related]
20. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P. Am J Cardiol; 2009 Jan 01; 103(1):93-102. PubMed ID: 19101237 [Abstract] [Full Text] [Related] Page: [Next] [New Search]